RxDoctor Payments Data

Colleen Hupp, DO

Vascular Surgery · Englewood, CONPI 1790805307

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 27.7% of the total. 2025 is the largest year on record at $798, 2.4 times the $330 reported in 2019. That places this record below the midpoint for vascular surgery clinicians in CO, where the typical reported total is $4,981.

$3,600in general payments, 2019–2025

Across 89 payments — averaging $40.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$996
  • Boston Scientific$329
  • Cvrx, Inc.$272
  • Tactile Systems Technology Inc$265
  • Shockwave Medical, Inc$230
  • Lemaitre Vascular, Inc.$218
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,45796%
  • Education$1444%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,600 in reported general payments places this provider in the 40th percentile of 66 vascular surgery providers in Colorado.

See all vascular surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$166,032
Medicare patients
261
Services billed
798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$11,165
ClopidogrelClopidogrel Bisulfate20$318
Oxycodone Hcl23$89
Amlodipine Besylate12$38
Tramadol Hcl14$34
Alprazolam28$20

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →